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Objectives- Diabetes and hypercholesterolaemia are known risk factors for the development of atherosclerosis and are 
considered to influence the development ofvein graft intimal hyperplasia. This study examines the combined effect of 
diabetes for 12 weeks (alloxan-induced) and hypercholesterolaemia for 8 weeks (1% cholesterol diet) on the formation of 
intimal hyperplasia and the vasomotor function of vein grafts. 
Materials and design, Thirty-two New Zealand White rabbits underwent a carotid vein bypass graft. Eight were controls, 
eight were diabetic, eight were hypercholesterolaemic and eight had both diabetes and hypercholesterolaemia. All vein grafts 
were harvested at 4 weeks postoperatively for morphology (n = 4) or contractility studies (n = 4). 
Results: Compared to controls, both diabetes and hypercholesterolaemia increased intimal thickness by 20% and 63% 
respectively; medial thicknesses of these vein grafts were unchanged compared to control. In contrast, diabetes with 
hypercholesterolaemia dramatically increased intimaI and medial thicknesses (1.8 fold and 1.6 fold respectively, compared 
to control). Smooth muscle cell contractility was enhanced in both the diabetic and hypercholesterolaemic groups. The 
presence of diabetes with hypercholesterolaemia did not further alter the enhanced smooth muscle cell contractile 
responses. 
Conclusions" This study suggests that the combination of both the atherogenic risk factors, hypercholesterolaemia and 
diabetes, ignificantly augments the formation of intimal hyperplasia n experimental vein grafts. 
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Introduction 
The development of intimal hyperplasia n a vein graft 
can lead to a haemodynamically significant stenosis 
within 2 years of insertion in up to 30% of peripheral 
bypasses. 1-3 If left untreated, these grafts fail and after 
either radiological or surgical interventions, the sub- 
sequent secondary patency is low. ~6 Intimal hyper- 
plasia results from the migration and proliferation of 
medial smooth muscle cells in the intima of the grafts 
followed by connective tissue deposition. 7 This pro- 
liferative lesion appears to be influenced by many 
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physical cellular and humoral factors. 7 Moreover, the 
presence of the risk factors, which are better associated 
with the development of spontaneous atherosclerosis 
(hyperlipidaemia, diabetes and hypertension), has 
been shown to contribute to the rapid development of 
intimal hyperplastic lesions in vein grafts. 8-12 
Although the singular effects of each of these risk 
factors have been assessed in experimental and 
clinical studies, the impact of the presence of two risk 
factors on the development of infimal hyperplasia in 
vein grafts has not been fully examined. 9 
In clinical studies, hyperlipidaemia is significantly 
correlated with the development of vein graft athero- 
sclerosis. 3'12'13 Hypercholesterolaemia increases the 
development of intimal hyperplasia in both experi- 
mental vein grafts and after experimental rterial 
8 14-16 angioplasty. • Diabetes appears to be a significant 
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factor in the development of restenosis following 
coronary angioplasty in clinical series, 17 and it has 
been shown to increase the formation of intimal 
hyperplasia n experimental vein grafts9 However, in 
contrast, the presence of mild systemic hypertension 
appears not to increase the development of intimal 
hyperplasia in experimental vein grafts. ~1'1s The con- 
tributions of a mixed atherogenic environment to the 
early development of intimal hyperplasia in a vein 
graft are still unclear. However, it has recently been 
shown that the combination of systemic hypertension 
and hypercholesterolaemia does not have an additive 
impact on the promotion of intimal hyperplasia 
development,  This study investigates the effect of 
the combined presence of diabetes and hypercholes- 
terolaemia on the development of intimal hyperplasia 
and on the changes induced in smooth muscle cell 
contractile phenotype within experimental vein grafts. 
When combined, hypercholesterolaemia and diabetes 
significantly augment he development of intimal 
hyperplasia nd the increase in the medial changes 
observed o not further alter the physiological pheno- 
type of the smooth muscle cells present. 
Material and Methods 
Thirty-two New Zealand White rabbits weighing an 
average of 2-2.5 kg underwent a right common 
carotid interposition vein bypass graft using the 
ipsilateral external jugular vein. Eight were controls, 
eight were diabetic (alloxan HC1 induced 100 mg/kg 
i.v.; maintained for 12 weeks), 1° eight were hyper- 
cholesterolaemic (100 g/day; 1% cholesterol diet for 8 
weeks; ICN Biomedical Inc., Cleveland, OH, U.S.A.) 
and eight had both diabetes and hypercholester- 
olaemia (alloxan induced diabetes for 12 weeks and 
placed on a 1% cholesterol diet for the final 8 weeks). 
Diabetes was present for 8 weeks prior to surgery and 
for 4 weeks after surgery. Hypercholesterolaemia was
present for 4 weeks prior to surgery and for 4 weeks 
after surgery. In the combined group, diabetes was 
present for 8 weeks and hypercholesterolaemia for 4 
weeks prior to surgery and both were maintained for 
4 weeks after surgery. All vein grafts were harvested at 
4 weeks postoperatively for morphology (n = 4) and 
contractility studies (n = 4). Total serum cholesterol 
concentrations were measured by the ferric chloride 
methodff Blood urea nitrogen and creatinine concen- 
trations were determined by a standard auto-analyser 
(Beckman Astra, Beckman Scientific Instruments, 
Irvine, CA, U.S.A.). Animal care complied with the 
"Principles of Laboratory Animal Care" as formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
issued by the National Institutes of Health. (U.S. 
Department of Health and Human Services, NIH 
Publication No. 80-23, revised 1985). 
Diabetic model 
Diabetes was induced in 16 animals by alloxan 
(median dose 100 mg/kg; Sigma Chemical Company, 
St Louis, MO, U.S.A.) given intravenously via an ear 
vein as described previously. 1°Animals were main- 
tained in the vivarium on normal chow with water ad 
libitum for the duration of the study. Blood glucose 
concentrations were determined every 14 days using a 
blood glucose meter (Ames Glucometer 3, Miles Inc., 
Elkhart, IN, U.S.A.) and an animal was considered 
diabetic if its random blood sugars were consistently 
greater than 13.3 mmol/1. 
Operative procedure 
Anaesthesia was induced and maintained with sub- 
cutaneously injected ketamine hydrochloride (60 rag/ 
kg, Ketaset, Bristol Laboratories, Syracuse, NY, U.S.A.) 
and xylazine (6 mg/kg, Anased, Lloyd Laboratories, 
Shenandoah, IA, U.S.A.). Antibiotic prophylaxis with 
30000 iu/kg of benzanthine and procaine penicillin 
(Durapen, Vedco Inc., Overland Park, KA, U.S.A.) was 
given intramuscularly at the time of induction. Sur- 
gery was performed using an operating microscope 
(JKH 1402, Edward Weck Inc., Research Triangle Park, 
NC, U.S.A.) under sterile conditions. After exposure 
through amidline longitudinal neck incision, the right 
external jugular vein was identified. Its branches were 
cauterised, at a distance from the vein to minimise 
injury, and it was then dissected out. Following 
excision, the vein was kept moist in a heparinised 
Ringer lactate solution (5 IU/ml, Heparin, Elkins-Sinn 
Inc., Cherry Hill, NJ, U.S.A.) for approximately 15min 
while the right common carotid artery was identified, 
dissected and both proximal and distal control 
obtained. Heparin (200 IU/kg) was administered 
intravenously. A proximal longitudinal arteriotomy 
was made and one end of the reversed jugular vein 
was anastomosed to the artery in an end-to-side 
manner using continuous 10-O microvascular mono- 
filament nylon suture (Ethilon, Ethicon Inc., Somer- 
ville, NJ, U.S.A.). The distal anastomosis was per- 
formed in a similar manner. Throughout the 
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procedure, care was taken to avoid unnecessary 
instrumentation of the vein graft. The right common 
carotid was ligated and divided between the two 
anastomoses with 4-0 silk sutures. Haemostasis was 
achieved and the wound was subsequently closed in 
layers. 
Harvest procedure 
Using the same anaesthetic regimen described above, 
the original incision was reopened and the vein graft 
isolated. Vessels for isometric tension studies were 
sectioned in situ into 5 mm segments, excised and 
immediately mounted in organ baths containing 
Krebs solution (vide infra). The animal was killed with 
an intravenous pentobarbital overdose (100 mg/kg, 
pentobarbital sodium, Anthony Products, Arcadia, 
CA, U.S.A.). For those vessels taken for histolog~ the 
proximal common carotid artery was cannulated 
following systemic heparinisation (200 IU/kg intra- 
venously). An infusion of Hanks Balanced Salt Solu- 
tion (HBSS, Gibco Laboratories, Life Technologies Inc., 
Grand Island, NY, U.S.A.) was begun and the animal 
killed. The infusion of HBSS was continued for 3 min 
at a pressure of 80 mmHg. Thereafter, fixation was 
commenced with a 5 min perfusion at room tem- 
perature of a 2% glutaraldehyde solution made up in 
a 0.1 mol/1 cacodylate buffer, pH 7.4, supplemented 
with 0.1 mol/1 sucrose to give a vehicle osmolarity of 
approximately 300 mOsm. The distal artery was then 
ligated and the fixative was left in the graft at a 
pressure of 80 mmHg. Simultaneousl~ the exterior of 
the graft and the attending vessels were soaked in the 
same fixative. After 60 min, the specimen was 
removed and glutaraldehyde-fixed for another 24 h at 
4 °C prior to further processing. All specimens were 
then processed for light microscopy. Following stan- 
dard procedures, the specimens were stained with a 
modified Masson's trichrome and Verhoeff's elastin 
stain. The intima and media were delineated by 
identification of the demarcation between the criss- 
cross orientation of the intimal hyperplastic smooth 
muscle cells and circular smooth muscle cells of the 
media. The outer limit of the media was defined by the 
interface between the circular smooth muscle cells of 
the media and the connective tissue of the adventitia. 
The area of the lumen, intima and media of each graft 
were quantified by videomorphometry (Innovision 
150, American Innovision Inc., San Diego, CA, U.S.A.). 
To determine the mean thickness of each layer, the 
luminal, intimal and medial radii were derived 
(area = ~r ~) and the intimal and medial thicknesses 
were calculated. An intimal ratio of the areas was also 
calculated (intimal area/[intimal +medial areas]). 
For scanning electron microscopy (SEM), mid- 
portion specimens of the glutaraldehyde-fixed grafts 
were rinsed with the same buffer solution as described 
above, dehydrated in ascending concentrations of 
ethanol, transferred to absolute acetone, critical point 
dried from CO2, mounted on specimen stubs and 
sputter-coated with gold-palladium according to stan- 
dard techniques. All specimens were examined in a 
Philips 500 scanning electron microscope (N.V. Phil- 
ips, Eindhoven, The Netherlands) at an accelerating 
voltage of 12 or 20 kV. For transmission electron 
microscopy (TEM), representative s ctions from the 
mid-portion of the glutaraldehyde-fixed grafts were 
post-fixed for I h at room temperature in 1% osmium- 
tetroxide dissolved in the same cacodylate buffer as 
used for the glutaraldehyde solution. After dehydra- 
tion in ascending concentrations of ethanol, the 
specimens were transferred to propylene oxide and 
finally embedded in Epon 812 monomer. Polymer- 
isation was carried out overnight at 40 °C followed by 
2 days at 60 °C. Ultrathin sections were cut with a 
diamond knife on a Reichart ultramicrotome (Reichart 
Optische Werke AG, Vienna, Austria), contrasted with 
uranyl acetate and lead citrate, and then examined in 
a Philips 300 transmission electron microscope (N.V. 
Philips, Eindhoven, The Netherlands) or a Zeiss 10A 
transmission electron microscope (Oberkochen, Ger- 
many) both operated at 40 or 60 kV. 
Isometric tension studies 
After harvesting as described above, 5 mm rings from 
each vein graft were suspended from two stainless 
steel hooks in 5 ml capacity organ baths containing 
oxygenated Krebs solution (122 retool/1 NaC1, 4.7 
mmol/1 KC1, 1.2 mmol/1 MgC12, 2.5 mmol/1 CaC12, 
15.4 retool/1 NaHCO3, 1.2 mmol/1 KI-I2PO 4 and 5.5 
mmol/1 glucose, oxygenated with a mixture of 95% 02 
and 5% CO2 at 37 °C). One hook was fixed to the 
bottom of the bath and the other was connected to a 
force transducer (Myograph F-60, Narco Bio-Systems, 
Houston, TX, U.S.A.). The isometric responses of the 
tissue were recorded on a multichannel polygraph 
(Physiograph Mk111-S, Narco Bio-Systems, Houston, 
TX, U.S.A.). The tissues were then placed under 0.5 g 
tension and allowed to equilibrate-in physiologic 
Krebs solution for 1 h. During the equilibration 
period, the Krebs solution was replaced every 15 rain. 
Following equilibration, the resting tension was 
adjusted in increments from 0.25-2.5 g and the 
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Table 1. Blood chemistry 
Control Diabetes Hypercholesterolaemia Diabetes / Hypercholesterolaernia 
Blood glucose 182+61 328 + 125" 174 + 54 285 + 37* 
Blood urea nitrogen 17_+4 22 _+ 2 23 + 1 23 _+ 1 
Creatinine 1.13_+0.13 1.14_+ 0.7 1.02_+ 0.05 1.24_+ 0.22 
Serum cholesterol 88_+11 91 _+ 13 1898 _+ 249* 2806 + 570* 
Concentrations of blood glucose, blood urea nitrogen, creatinine and cholesterol in control (n=8), hypercholesterolaemia (n=8), diabetes (n=8) 
and diabetes/hypercholesterolaemia (n=8) nimals at harvest. Values are the mean + S.E.M. expressed as mg/dl. There are significant 
differences in the blood glucose between the non-diabetic and diabetic groups. Serum cholesterol is four-fold higher in the two groups on the 
1% cholesterol diet. Blood urea and creatinine are similar between the four groups. 
*p<0.05. 
contractile response to a modified oxygenated Krebs 
solution (60 mmol / l  KC1, 66.7 mmol/1 NaC1, 1.2 
mmol/1 MgC12, 2.5 mmol/1 CaC12, 15.4 retool/1 
NaHCO3, 1.2 mmol/1 KH2PO 4 and 5.5 mmol/1 glu- 
cose) was determined to establish a length-tension 
relationship. The tension at which a ring generated its 
maximal contractile response to the modified Krebs 
solution was considered the optimal resting tension 
for that particular ing, and the ring was set at this 
tension for subsequent studies. Norepinephrine 
(10-9-10 -5 mol/1) was added cumulatively in half 
molar increments and the isometric tension developed 
by the tissue was measured. After washout and re- 
equilibration, dose response curves were obtained for 
bradykinin (10-~°-10 -~ mol/1), histamine (10--8-10 -3 
mol/1) and serotonin (10-9-10 -5 mol/1). For all experi- 
ments, the same agonist was added to each chamber in 
the same sequence to control for possible previous 
exposure-induced changes in subsequent responsive- 
ness. These preparations retain reproducible con- 
tractile properties for up to 12 h. All compounds were 
obtained from Sigma Chemical Co. (St. Louis, MO, 
U.S.A.) and were dissolved in distilled water with the 
exception of norepinephrine which was dissolved in 
10 -3 tool/1 HC1. 
KC1). Data are expressed as the mean + standard error 
of the mean (S.E.M.) with n equaling the number of 
animals studied. Statistical differences between 
groups were tested by multifactorial analysis of 
variance (MANOVA) using a Duncan post-hoc test, 
when appropriate, and a p-value less than 0.05 was 
regarded as significant. 
Results 
General 
All animals survived to harvest and all grafts were 
patent. The serum cholesterol concentration of the 
cholesterol-fed animals were significantly greater than 
the control or diabetic animals (Table 1). Likewise, 
blood sugars of the non-cholesterol and cholesterol fed 
diabetic animals were significantly greater than the 
non-cholesterol and cholesterol fed, non-diabetic ani- 
mals (Table 1). Serum biochemistry was equivalent in 
the four groups of animals (Table 1). The recorded 
mean arterial blood pressures were not different 
between the four groups of animals at harvest. 
Data and statistical analysis 
The isometric responses of the rings were converted to 
percent maximal response and were plotted against 
the negative logarithm of the agonist dose to produce 
dose response curves. The ECs0 value (the concentra- 
tion for the half maximal response) for contraction or 
relaxation of each ring was calculated by logistic 
analysis 2° and is expressed as the pD2 (defined as 
-lOgl0[ECs0]). The actual maximal contractile response 
to each agonist is expressed in milligrams of force 
generated and is then standardized to the contractile 
ratio (contractile ratio = actual maximal contraction to 
an agonist/actual maximal contraction to 60 mmol/1 
Morphology 
At harvest, there were areas of visible intramural 
accumulations of cholesterol in the middle and distal 
segments of the grafts from the hypercholesterolaemic 
and hypercholesterolaemia/diabetic animals only. All 
vein grafts developed intimal hyperplasia which was 
characterised, on light microscop)~ by a random criss- 
cross orientation of the smooth muscle cells in the 
intima with slender smooth muscle cells in the media 
which were arranged in a regular circular pattern. 
There were varying degrees of connective tissue 
interspersed between the smooth muscle cells. The 
light microscopic appearance of the diabetic vein 
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Table 2. Dimensional analysis 
Control Diabetes Hypercholesterolaemia Diabetes / Hypercholesteroaemia 
Intimal area (mm 2) 0.87_+ 0.12 1.74 _+ 0.34* 2.53_+0.29** 2.72 + 0.80** 
Medial area (mm 2) 1.03 _+ 0.12 1.45 _+ 0.34 1.41+0.15" 3.07 + 1.45"*+ 
lntimal ratio 0.45_+ 0.04 0.55_+ 0.03* 0.64+0.01" 0.53_+ 0.04*t 
Values are the mean + S.E.M. Intimal ratio = [infimal area]/[intimal + medial are s]. 
*p<0.05, **p<0.01 compared to control vein graft; +p<0.05 for the effect of diabetes on hypercholesterolaemic vein grafts. 
grafts were similar to the control vein grafts. In the 
vein grafts from animals fed with a high cholesterol 
diet, there were areas in the intimal hyperplasia of 
lipid accumulation, and many foam cell formation and 
lipid containing smooth muscle cells were observed; 
these were better defined in electron microscopy. 
The dimensional analysis of the control and diabetic 
vein grafts are shown in Table 2. There was a two-fold 
increase in the area of intimal hyperplasia in the 
diabetic vein grafts compared to the control vein grafts 
with the intimal ratio showing a 22% increase (Table 
2). There was no significant difference in the medial 
areas between the control and diabetic vein grafts. The 
presence of hypercholesterolaemia increased the inti- 
real area by nearly three-fold while the medial area 
increased by 37% compared to control group (Table 2). 
Hypercholesterolaemia significantly increased the 
intimal ratio (42%) of the vein grafts. The intimal area 
of the combined disease group was similar to the 
hypercholesterolaemic group (Table 2). However, in 
contrast to the hypercholesterolaemic group, there 
was a two-fold increase in medial areas of the vein 
grafts. This medial area was three-fold greater than the 
control vein grafts (Table 2). With the combined 
increase in intimal and medial areas, the intimal ratio 
was reduced compared to the hypercholesterolaemia 
but remained 17% greater than the contro ! group. 
Compared to control vein grafts, the presence of 
diabetes resulted in a 20% increase in intimal thickness 
without a change in medial thickness (Figs. 1 and 2), 
while the presence of hypercholesterolaemia pro- 
duced a 63% increase in intimal thickness without a 
change in medial thickness (Figs. 1 and 2). In the 
presence of both diabetes and hypercholesterolaemia, 
the thickness of the intima and the media of the vein 
grafts was significantly increased (177% and 158%, 
respectively) compared to the control group or com- 
pared to the vein grafts from either the diabetic or the 
cholesterol-fed animals (Figs. 1 and 2). 
In SEM, the vein grafts from the control group were 
completely covered by intact sharply outlined endo- 
thelial cells with occasional junctional stomata (Fig. 3). 
The vascular surface of the vein grafts from the 
diabetic group differed considerably from that of the 
control group. Most notable was the absence of the 
surface microextensions, the wavy cell borders with 
increased numbers of stomata, and occasional clefts in 
the intercellular junctions of the endothelium (Fig. 4). 
In the vein grafts from both groups of cholesterol-fed 
animals, the endothelial cells had faint and indistinct 
A B 
Fig. 1. A composite photomicrograph of a cross-section f the wall of a control vein graft (A),diabetic vein graft (B),hypercholesterolaemic 
vein graft (C) and hypercholesterolaemia with diabetes vein graft (D). I = intimal hyperplasia, m = media. The arrows indicate the 
demarcation between the intimal hyperplasia and the media. Magnification ×100 (reproduced here at 80%). 
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cellular outlines. There were more frequent stomata on 
the surface with fingerlike extensions and occasional 
breaks at the endothelial cell borders (Figs. 5 and 6). 
The peculiar shallow surface depressions of the 
endothelial cells are shrinking artefacts due to dehy- 
dration corresponding to the sites of the cytoplasmic 
large vacuoles seen in transmission electron micros- 
copy (Figs. 9 and 10). The fractures and perforations 
are, on the other hang a result of the impact of 
the electron beam suggesting a fragile/friable 
endothelium. 
In transmission electron microscop)4 common mor- 
phological features of all the vein grafts were the 
numerous layers of smooth muscle cells (SMCs) 
representing the development of intimal hyperplasia. 
The SMCs were embedded in a matrix containing 
poorly developed and disorganised connective le- 
ments. In the control vein grafts, the vascular surface 
was covered by a monolayer of intact endothelial cells. 
The SMCs of the subendothelium were predominantly 
of a contractile phenotype. Only a few synthetic 
phenotypes were observed (Fig. 7). Compared with 
the control vein grafts, the endothelial cells of the 
diabetic vein grafts appeared relatively thicker than 
those in the control vein grafts and contained greater 
amounts of ribosomes. However, unlike the grafts 
from either the control or cholesterol-fed animals, the 
~9 
u 
Control Diabetic Hyper- Cholesterol 
cholesterolemia and 
Diabetes 
Fig. 2. The intimal and medial thicknesses of the graft wall of the 
control, diabetic, hypercholesterolaemic andhypercholesterolaemia 
with diabetes groups. Values are the mean thickness in ~m. ([~) 
intima; ( I )  media. 
Fig. 4. Scanning electron microscopy of the vascular surfaces of a 
diabetic vein graft. The surface ultrastructure of the endothelium 
from the diabetic vein graft is dramatically different from that seen 
in the control vein graft. The bulging endothelial cells (EC) are 
almost devoid of surface processes (white dots). Stomata (S) can be 
identified in the cell borders (arrowed) which, in these grafts, are 
characterised by their wavy pattern (arrows). Magnification × 2200 
(reproduced here at 50%). 
Fig. 3. Scanning electron microscopy of the vascular surfaces of a 
control vein graft. The vascular surface of the control vein graft is 
covered with bulging, oval-shaped endothelial cells (EC) that have 
distinct cell borders (arrows). The surface of each cell is covered 
with abundant minor surface extensions (white dots). Magnification 
x 2200 (reproduced here at 50%). 
Fig. 5. Scanning electron microscopy of the vascular surface of a 
hypereholesterolaemic vein graft. The hypercholesterolaemic vein 
graft has flat irregularly outlined endothelial cells (EC) with a scanty 
number of surface processes (white dots). Long finger-like struc- 
tures (arrowed) often extend from the slightly wavy cell borders. 
Note the peculiar ound and shallow surface depressions (*). The 
few surface fractures (F) and minor surface perforations (arrow- 
heads) represent artifacts caused by the impact of the electron beam 
and suggesting a fragile/friable endothelium. Magnification 
x 2200 (reproduced here at 50%). 
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endothelial cells of the diabetic vein grafts revealed 
predominantly narrow intracellular contact points and 
Fig. 6. Scanning electron microscopy of the vascular surface of a 
hypercholesterolaemic anddiabetic vein graft. Apart from minor 
differences in cellular outlines a d curvature, the surface of the 
endothelial cells (EC) lining the hypercholesterolaemia with dia- 
betes vein grafts is almost identical wi h that of the hyper- 
cholesterolaemic vein grafts. Finger-like surface processes at the cell 
borders (arrowed), stomata (S) minor surface perforations (arrow- 
head) and shallow depressions (*) are readily identified. Magnifica- 
tion x 2200 (reproduced here at 50%). 
occasional gaps (stomata) between adjacent endothe- 
lial cells. In the subendothelium, the vast majority of 
the SMCs were characterised as synthetic phenotypes 
(Fig. 8). However, unlike the grafts from the control 
and cholesterol fed animals, the endothelial cells of the 
diabetic vein grafts had narrow intracellular contact 
points and occasional gaps between adjacent endothe- 
lial cells (Fig. 8). In the subendothelium, the vast 
majority of the SMCs were characterised by synthetic 
phenotypes (Fig. 8). The luminal surface of the vein 
grafts from the cholesterol fed animals was covered by 
a continuous layer of relatively thick endothelial cells. 
Beneath this monolayer, there were multiple layers of 
smooth muscle cells (Figs. 9 and 10). Many of the 
endothelial cells and smooth muscle cells contained 
numerous cytoplasmic vacuoles and enhanced num- 
bers of ribosomes. Interspersed between the smooth 
muscle cells, there were vacuole-filled macrophages 
(foam cells). Macrophages with little or no lipid 
accumulation could be identified deeper in the wall 
(Figs. 9 and 10). The number  of foam cells and 
macrophages present varied from region to region in 
the graft wall in both cholesterol fed groups. In 
general, the numbers of foam cells in the vessel wall 
and the number  of macrophages at the adventitial 
Fig. 7. Transmission electron micrograph of the cross-section of walls fr m a control vein graft. A common finding of the subendothelium 
in all groups is the intimal hyperplasia composed of numerous layers of smooth muscle cells (SMC) embedded in a matrix of poorly 
developed and organised connective tissue (*). The control vein graft shows well defined endothelial cell (EC) with convex surfaces. A 
slender surface extension (arrowed) is seen adjacent to the intercellular junction. The majority of the intimal smooth muscle cells (SMC1) 
were largely filled with myofilaments (contractile phenotypes). However, scattered smooth muscle cells (SMC2) containing abundant free 
and membrane bound ribosomes (synthetic phenotypes) were identified. Note the poorly developed and disorganised connective tissue. 
Magnification x 2200 (reproduced here at 80%). 
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Fig. 8. Transmission electron micrographs of the cross-section ofwalls from a diabetic vein graft. A common finding of the subendothelium 
in all groups is the intimal hyperplasia composed of numerous layers of smooth muscle cells (SMC) embedded in a matrix of poorly 
developed and organised connective tissue (*). The ultrastructural pattern of the diabetic vein graft differ from the control vein grafts. Most 
notable is the abundance of smooth muscle cells (SMC) of the synthetic phenotype, ndothelial cells (EC) with an enhanced amount of free 
and membrane bound ribosomes in their cytoplasm and the peculiar morphology of the intercellular junctions (IJ). Commonly, such 
junctions are composed of long and thin cellular processes overlapping each other (8B and 8C) or making end-to-end contacts (8D). The 
adjacent cell membranes are interconnected by desmosomes (arrowheads). Intercellular stomata (S) are occasionally identified (8E). 
Magnification × 2200 (reproduced here at 80%). 
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surface in the cholesterol-fed diabetic animals (Figs. 9 
and 10) were less than in the cholesterol-fed. 
Physiological responses 
Compared to control vein grafts, the presence of 
hypercholesterolaemia enhanced while diabetes did 
not change smooth muscle cell contractility in vein 
grafts. The combined presence of hypercholester- 
olaemia nd diabetes maintained the overall enhanced 
vasoreactivity of the vein grafts induced by hyper- 
cholesterolaemia (T bles 3 and 4). Vein grafts from the 
control and diabetic groups responded in a concentra- 
!J 
Fig. 9. Transmission electron micrographs of the cross-section of walls from a hypercholesterolaemic vein graft. A common finding of the 
subendothelinm in all groups is the intimal hyperplasia composed of numerous layers of smooth muscle cells (SMC) embedded in a matrix 
of poorly developed and organised connective tissue (*). A characteristic ultrastructural feature of the hypercholesterolaemic vein grafts are 
the large vacuoles residing in the cytoplasm of both the ndothelial (EC) and smooth muscle cells (SMC). In addition, the subendothelium 
contains numerous vacuole-filled cells: foam cells (FC) and macrophages (M). The latter cells are characterised by the long and slender 
surface processes and the intracellular vacuoles with electron dense debris (*). The profile of the intercellular junctions varies from a 
transverse (IJ; 9A) to a diagonal orientation (arrowheads). Note the long, slender surface processes (arrows) at the cell borders. The majority 
of the smooth muscle cells are characterised as synthetic phenotypes. P =blood platelets. Magnification × 2200 (reproduced here at 
80%). 
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t ion dependent  manner  to norep inephr ine ,  serotonin,  
b radyk in in  and  h is tamine w i thout  s ignif icant changes 
in their  respect ive sensit iv it ies (Table 3). The actual  
max imal  contract ions to norep inephr ine ,  serotonin,  
h is tamine and  bradyk in in  were increased in the 
diabet ic  vessels compared  to controls. In addi t ion,  in 
the diabet ic  ve in  grafts, there was  an increase in the 
max imal  contract ions generated  in response to KC1 by  
EC 
Fig. 10. Transmission electron micrographs ofthe cross-section f the walls of a hypercholesterolaemic and diabetic vein graft. A common 
finding of the subendothelium in all groups is the intimal hyperplasia composed of numerous layers of smooth muscle cells (SMC) 
embedded in a matrix of poorly developed and organised connective tissue. The hypercholesterolaemia withdiabetes vein graft shows an 
ultrastructural pattern very similar to the hypercholesterolaemic vein graft. However, the smooth muscle c lls (SMC) appear less 
vacuolated. Furthermore, foam cells are less numerous and accumulate predominantly in the upper part of the subendothelium. No
characteristic macrophages were identified, although the long and slender cytoplasmic processes (large arrows) seen in 10B strongly 
indicates transformation f a macrophage into a foam cell. Minor surface processes on the endothelial cells are indicated by small arrows. 
Magnification × 2200 (reproduced here at 80%). 
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Table 3. Sensitivity in control and diseased vessels 
Control Diabetes Hypercholesterolaemia Diabetes / Hypercholesteroaemia 
Norepinephrine 6.09 + 0.09 6.15 +_ 0.13 6.40 ± 0.09* 6.43+0.22 
Serotonin 6.20 + 0.15 6.21 _+ 0.10 6.89 ± 0.06** 6.21+0.11+ 
Bradykinin 5.60 _+ 0.15 6.49 _+ 0.33 6.30 + 0.10" 6.17_+0.09 
Histamine 5.13 _+ 0.10 4.88 + 0.15 5.47 _+ 0.18" 5.07+0.11 
The EC50 values to the agonists in control and diseased vessels. Values are the mean _+ S.E.M. of the pD2. 
* p < 0.05, ** p < 0.01 compared to control vein graft; tp < 0.05 for the effect of diabetes on hypercholesterolaemic vein grafts. 
Table 4. Maximal responses in control and diseased vessels 
Control Diabetes Hypercholesterolaemia Diabetes/Hypercholesteroaemia 
Norepinephrine 1.62 + 0.37 1.47 + 0.39 2.13 + 0.19" 1.18 +_ 0.14-t 
Serotonin 0.41 + 0.27 1.04 + 0.30* 4.19 + 0.03** 2.25 + 0.32"~-t 
Bradykinin 0.38 + 0.21 0.42 _+ 0.11 2.40 __. 0.13"* 1.29 + 0.29**-H- 
Histamine 1.69 + 0.15 2.37 + 0.35* 0.60 _+ 0.03* 0.68 + 0.14" 
The maximal responses to the agonists in control and diseased vessels. The KC1 responses are 300 + 33 mg, 519 + 138 mg, 216 + 30 mg and 
280 + 40 mg for the control, diabetes, hypercholesterolaemia and diabetes/hypercholesterolaemia groups respectively. Values are the mean _+ 
S.E.M. of the contractile ratio. 
* p < 0.05, ** p < 0.01 compared tocontrol vein graft; tp < 0.05, t'~p<0.01 forthe effect of diabetes on hypercholesterolaemic vein grafts. 
the vein grafts from diabetic group (519 _+ 138 mg) 
compared to controls (300 + 33 mg). However, when 
the contractile responses are standardised to this KC1 
response, only the maximal contractions to serotonin 
and histamine remain significantly increased in the 
diabetic group (Table 4). Hypercholesterolaemia 
increased the sensitivity of the vein grafts to nor- 
epinephrine, serotonin, bradykinin and histamine 
(Table 3). The maximal actual contractile forces gen- 
erated in response to potassium chloride (216 + 30 
rag) and histamine were reduced, those to nor- 
epinephrine were unchanged, while those to bradyki- 
nin were increased by the presence of hypercholester- 
olaemia (Table 4). 
There were significant statistical interactions 
between diabetes and hypercholesterolaemia when 
the combined presence of hypercholesterolaemia and 
diabetes in vein grafts was tested in the MANOVA 
model (p<0.05). Subsequent analyses, therefore, 
examined two subsets: the impact of hypercholester- 
olaemia on diabetic vein grafts and the impact of 
diabetes on hypercholesterolaemic vein grafts. The 
presence of diabetes in hypercholesterolaemic vein 
grafts significantly decreased the sensitivity of the 
serotonin responses (Table 3). There were no sig- 
nificant changes in the sensitivity of the responses 
elicited by norepinephrine, bradykinin and histamine 
(Table 3). Furthermore, there were no significant 
changes in the actual maximal responses induced by 
the potassium chloride, norepinephrine, serotonin, 
bradykinin or histamine (Table 4). The presence of 
high cholesterol concentrations in the diabetic vein 
grafts produced no significant changes in the sensitiv- 
ity of the responses to any of the contractile agonists 
tested (Table 3). However, there was a significant 
decrease in the maximal contractions induced by KC1 
(280 + 40 mg), norepinephrine and histamine while 
the maximal response to serotonin increased and that 
to bradykinin remained unchanged (Table 4). 
Discussion 
After insertion into the arterial circulation, vein grafts 
consistently develop intimal hyperplasia which histo- 
logically, is a combination of increased numbers of 
smooth muscle cells and connective tissue synthesised 
by the smooth muscle cellsY The processes leading to 
the development of vein graft intimal hyperplasia 
begin after implantation, with smooth muscle cell 
migration from the media and proliferation within the 
intima. 7"9'22 In time, this proliferative phase is fol- 
lowed by a more chronic phase of connective tissue 
deposition. Over one quarter of peripheral vein 
bypass grafts develop significant stenotic lesions 
within one year of implantation and histologically, the 
majority of these lesions can be defined as intimal 
hyperplasia. 3'9 Thus, studies designed to delineate 
those factors which may accelerate the development of
intimal hyperplasia nd means to control its formation 
are of considerable interest. Based on the similarities 
in their respective pathologies, intimal hyperplasia 
and spontaneous atherosclerosis have been grouped 
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within the same spectrum of vascular disease termed 
"accelerated atherosclerosis". 23 
The serum cholesterol concentrations are high in 
this study and exceed those usually measured in 
hypercholesterolaemic patients. The markedly ele- 
vated levels are due to the cholesterol metabolism of 
the rabbit and the diet used. These higher serum 
cholesterol concentrations induce rapid atheroma 
development in the rabbit and have been used as a 
model for human atheroma. Thus, although the serum 
cholesterol concentrations on a 1% diet are obviously 
not clinically applicable, the resulting atheromatous 
lesions can be. The intimal hyperplasia of human vein 
grafts retrieved one month after aorto-coronary 
bypass appear to consist mainly of proliferating 
smooth muscle cells with only scattered macrophages 
in the subendothelium. 24'25 The intimal hyperplastic 
lesions of vein grafts from the cholesterol fed animals 
in this study are composed predominantly of lipid- 
laden smooth muscle cells between which are macro- 
phages in various stages of foam cell formation. The 
intimal hyperplasia develops more rapidly in these 
vein grafts compared to controls,  Functionall~ 
hypercholesterolaemia induces upersensitivity of the 
vein grafts to all the contractile agonists. There are 
suggestions that the probable mechanism for this 
increased contractility are altered receptor-independ- 
ent calcium mediated responses. 26Low levels of low 
density lipoproteins have been documented to alter 
calcium metabolism ofvascular smooth muscle cells. 27 
Specificall~ the augmented serotonin response in 
hypercholesterolaemia has been suggested to be due 
to the direct interaction of oxidised low density 
lipoproteins with smooth muscle cells, an increase in 
serotonin activated Ca 2+ influx and/or an increase in 
smooth muscle cell--cell to cell coupling. 28 Such 
functional changes may be considered markers for the 
subsequent development of atherosclerosis. 29'3° Clini- 
call~ the presence of diabetes, usually of the non- 
insulin dependent variant, does not significantly affect 
long-term vein graft patency. 31"32 The endothelial 
linings of the vein grafts from the diabetic group 
showed ultrastructural changes compared to those of 
the control or the hypercholesterolaemic vein grafts, 
giving an impression of poor endothelial integrity. The 
alterations in endothelial cell morphology may be 
associated with the increase in intimal hyperplasia 
observed. Although there were significant morpho- 
logical changes in the endothelium of these vein 
grafts, the presence of diabetes did not change the 
sensitivity of the vein grafts to any of the contractile 
agonists compared to controls. Morphologicall~ the 
smooth muscle cells in the intimal hyperplasia were 
similar to the control vein grafts. These findings 
suggest that, from both an ultrastructural and physio- 
logical perspective, the smooth muscle cell phenotype 
has not been further modulated by diabetes, even 
though the volume of smooth muscle cells present has 
obviously increased. This is, in contrast, to results in 
the hypercholesterolaemic group, where an increased 
intimal thickness was associated with significantly 
altered smooth muscle cell morphology and 
contractility. 
In the group of animals with the combination of 
hypercholesterolaemia and diabetes, there were fur- 
ther morphological changes compared to either the 
control hypercholesterolaemic or diabetic groups. 
Both the intimal and  medial layers showed sub- 
stantive proliferative responses. Although diabetes 
induces an intimal response, it does not change the 
physiological phenotypes present. Therefore, the dra- 
matic response observed in both layers probably 
reflects the physiological changes primarily induced 
in the smooth muscle cells by hypercholesterolaemia. 
This study demonstrates that when cholesterol-modu- 
lated smooth muscle cells are additionally stimulated 
by the high serum glucose concentrations i  vivo, there 
is a resultant intimal and a medial growth response. 
This does not happen when hypertension is combined 
with hypercholesterolaemiaY Ultrastructurall~ the 
vein grafts from the combination of hypercholester- 
olaemia and diabetes had less numerous foam cells 
than the hypercholesterolaemic group and these cells 
were predominantly ocated in the subendothelium. 
There were fewer foam cells deep in the wall and the 
numbers of macrophages at the adventitial surface 
were also decreased. Other studies on the combination 
of hypercholesterolaemia and diabetes in the rabbit 
have suggested that the degree of net lipid transfer 
into the arterial wall and the mural cells is less than in 
hypercholesterolaemia alone. 33-35 This is due to an 
accumulation of large triglyceride-rich lipoproteins 
that do not permeate the vessel wall. These observa- 
tions could explain the apparent decrease in intramu- 
ral lipid accumulation i this study. 
The increased intimal and medial thicknesses in the 
presence of hyperlipidaemia and diabetes are con- 
sistent with the present understanding of ather- 
ogenesis, that the presence of both conditions results 
in accelerated atheosclerotic lesion formation. How- 
ever, the mechanisms, whereb~ such an exaggerated 
response is mediated are unclear. One explanation is
that hyperglycaemia is critical to the diabetes-induced 
vascular proliferative responses. 3s'B6 It has been 
shown that serum from diabetic humans can stimulate 
the growth of cultured fibroblasts, mooth muscle cells 
and endothelial cellsY Furthermore, hyperglycaemia 
induces non-enzymatic glycosylation of key cellular 
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proteins to produce acute glycosylation endproducts 
(AGE). 35'36 AGE are capable of modulating cellular 
responses to growth factors and cytokines and may be 
responsible for the altered morphology and vascular 
responses observed in diabetes. These AGEs react 
with specific AGE receptors on both endothelial and 
smooth muscle cells, induce cytokine production in 
macrophages, increase vascular permeability and 
inactivate nitric oxide. 35'36 Moreover, AGE receptors 
have been documented on macrophages. Stimulation 
of these macrophage AGE receptors increases macro- 
phage monokine synthesis and secretion. These mono- 
kines (cachectin, TNF and IL-1) increase cell prolifera- 
tion and matrix synthesis directly, and indirectly 
induce growth factor synthesis and release from 
endothelial cells. 35'36 The presence of diabetes, and in 
particular, high glucose concentrations increase lipo- 
protein oxidation. Oxidized LDLs are significant 
stimuli of smooth muscle cell proliferation and endo- 
thelial cell dysfunction. 38These effects, in combination 
with the effects of high lipid concentrations on 
macrophages and vessel endothelial and smooth 
muscle cells, could explain the considerable increased 
intimal and medial hyerplasia development seen in 
the vein grafts of the combined hypercholesterolaemia 
and diabetes animals. 
The contractility of the smooth muscle cells in the 
vein grafts from the combined hypercholesterolaemia 
with diabetes animals appears to reflect predom- 
inantly the presence of hypercholesterolaemia. The
presence of diabetes in the hypercholesterolaemic ve n
grafts did not further augment the contractile 
responses elicited, whereas the addition of a choles- 
terol diet to diabetic animals induced sensitivities 
closer to those observed in the cholesterol fed group. 
There was a notable xception, in that the response to 
serotonin decreased. The precise reason is unclear. 
However, from previous studies, the responses to 
serotonin in vein grafts appear to correlate with the 
intimal ratio which reflects both intimal and medial 
dimensions rather than intimal thickness, '39 The vein 
grafts in the combined hypercholesterolaemia with 
diabetes group had intimal ratios much lower than 
those from the hypercholesterolaemia group alone, 
which can be accounted for by the significant medial 
response observed in the combined hypercholester- 
olaemia with diabetes group. 
In conclusion, the combination of both the athero- 
genic risk factors, hypercholesterolaemia and diabetes, 
significantly augments the formation of intimal hyper- 
plasia in experimental vein grafts, without further 
aggravating the alterations in smooth muscle cell 
physiological phenotype induced by the systemic 
vascular diseases. 
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